Lupin receives tentative approval from USFDA for Amifampridine Tablets
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
This product has sales of about US$ 20 million in Europe
Subscribe To Our Newsletter & Stay Updated